Virax Biolabs Group [VRAX]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 107.72% | 107.72% | 76.94% |
| Loss % | -23.75% | -23.75% | 0.00% |
| Duration | 13.3d | 14d | 2.1d |
| Total Pivots Found | 4 |
| Gain/Loss Legs | 3 (2 Gain / 1 Loss) |
| Last Pivot | Top @ $0.32 on 2026-05-20 |
| Change since Last Pivot | $-0.14 (-42.32%) |
Next Pivot Prediction Last: $0.18
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $0.24 |
| Predicted Price (Median) | $0.24 |
| Predicted Price Range (~68%) | $0.24 - $0.24 |
| Change to Avg Target | $0.06 (32.20%) |
| Predicted Date (Avg) | 2026-06-02 |
| Predicted Date Range (~68%) | 2026-05-31 - 2026-06-04 |
| Basis | Based on 1 historical losses (Avg: -23.75%, Median: -23.75%, StdDev of Abs: 0.00%) and duration (Avg: 13.3 days, StdDev: 2.1 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Modest rise for Virax Biolabs Group.
Virax Biolabs Group (VRAX) stock price advanced on Friday after the stock rose $0.00160 (0.88%) from the previous session on extremely light volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 0.31% rise. With 728 684 shares traded, volume yesterday reached $134 078. This was 318 816 shares less than the prior day. Compared to the 10-day average of 5.26M shares, volume was less than the average.
Virax Biolabs Group signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-23.3%), medium- (-23.3%), and long-term (-23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Virax Biolabs Group Support & Resistance Levels
The stock is trading above the closest support level at $0.166. approximately $0.0180 (9.78%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s10.166 -
Virax Biolabs Group Evaluation
- Short score: -2.24
- Medium score: -2.94
- Long score: -3.75